Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Dietary fructose effects on lipoprotein metabolism and risk for coronary artery disease Hollenbeck CBAm J Clin Nutr 1993[Nov]; 58 (5 Suppl): 800S-809SIn this chapter I have attempted to review the current literature drawing on those studies that I believe provide the best scientific evidence in regard to this issue. When those studies that provide the best scientific evidence are reviewed, there is evidence that increasing dietary fructose consumption can significantly increase fasting plasma triglyceride and cholesterol concentrations. Specifically, these changes are associated with an increase in both VLDL and LDL particles, without any apparent change in HDL particle concentrations. It appears that the magnitude of the deleterious effects vary depending on such factors as age; sex, baseline glucose, insulin, and triglyceride concentrations; the presence of insulin resistance; and the amount of dietary fructose consumed. Finally, not all studies are consistent in these findings, however, the positive data cannot easily be dismissed and may be of substantial clinical importance. This is particularly true given the fact that: 1) these deleterious changes occur in the absence of any beneficial effect on lipoprotein metabolism, and 2) these abnormalities in lipoprotein metabolism appear to be greater in those individuals already at an increased risk for coronary artery disease.|Clinical Trials as Topic[MESH]|Coronary Disease/*epidemiology/metabolism[MESH]|Dietary Carbohydrates/*pharmacology[MESH]|Fructose/*pharmacology[MESH]|Humans[MESH]|Lipoproteins/*metabolism[MESH]|Risk Factors[MESH] |
